Date | Name | Shares | Transaction | Value |
Mar 7, 2025
| Davide Barbon SVP & President, MT and APAC |
21,953
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Michael Guhde SVP and President, CCT |
5,735
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Bartek Makowiecki See Remarks |
26,330
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Bartek Makowiecki See Remarks |
19,820
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Emmanuel Caprais Senior Vice President & CFO |
42,330
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.99 per share |
5,671,796.70
|
Mar 7, 2025
| Emmanuel Caprais Senior Vice President & CFO |
45,171
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.99 per share |
6,052,462.29
|
Mar 7, 2025
| Emmanuel Caprais Senior Vice President & CFO |
53,691
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Emmanuel Caprais Senior Vice President & CFO |
35,294
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Davide Barbon SVP & President, MT and APAC |
24,613
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.99 per share |
3,297,895.87
|
Mar 7, 2025
| Davide Barbon SVP & President, MT and APAC |
25,791
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.99 per share |
3,455,736.09
|
Mar 7, 2025
| Davide Barbon SVP & President, MT and APAC |
29,196
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Luca Savi President and CEO; Director |
283,230
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Emrana Sheikh See Remarks |
4,050
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Lori B. Marino See Remarks |
11,920
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Cheryl de Mesa Graziano Vice President & CAO |
5,409
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.99 per share |
724,751.91
|
Mar 7, 2025
| Cheryl de Mesa Graziano Vice President & CAO |
5,575
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $139.43 per share |
777,322.25
|
Mar 7, 2025
| Cheryl de Mesa Graziano Vice President & CAO |
5,843
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Luca Savi President and CEO; Director |
333,523
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.99 per share |
44,688,746.77
|
Mar 7, 2025
| Luca Savi President and CEO; Director |
344,196
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.99 per share |
46,118,822.04
|
Mar 7, 2025
| Luca Savi President and CEO; Director |
363,875
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|